Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity

This study has been completed.
Sponsor:
Collaborators:
Information provided by:
University of Michigan
ClinicalTrials.gov Identifier:
NCT00240058
First received: October 13, 2005
Last updated: November 2, 2006
Last verified: November 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given